The parenteral nutrition market is set to witness substantial growth by 2027 owing to increasing number of pre-mature births across the globe. Additionally, mounting prevalence of chronic diseases is expected to further support market growth through the forecast period.

Parenteral nutrition involves administering patients with vital life supporting nutrients through the veins and bypassing the gastrointestinal tract. This method of feeding is typically offered to premature newborns or individuals who are incapable of absorbing necessary nutrients from their food to sustain. Notably, growing geriatric population, rising incidences of metabolic disorders, and pre-mature infants globally have played a vital role in fueling market demand.

Moreover, major industry participants are employing lucrative techniques to tap into emerging marketplaces through acquisitions, alliances, mergers, and product launches, which has positively impacted the global business landscape. For instance, in November 2020, Grifols, a major healthcare firm, inked a strategic alliance with B. Braun Melsungen AG, a leading medical devices company, to enhance therapy safety and pharmacy manufacturing output.

Citing another instance, in August 2021, Baxter International Inc., a prominent medical products manufacturer, collaborated with Amazon Web Services (AWS) to facilitate its digital transformation by leveraging cloud technology. Subsequently, technological integration and expansion strategies implemented by industry players have augmented market expansion.

The parenteral nutrition market has been categorized based on composition, end-use, consumer, and region. On the basis of composition, the market has further been segmented into fats, amino acids, minerals, trace elements, carbohydrates, vitamins, and others.

The fats composition segment garnered a valuation of around USD 986 million in 2020 and is calculated to grow at a robust pace over 2021-2027 due to numerous applications and favorable clinical outcomes related with the use of fats in parenteral nutrition products.

In terms of consumer, the market has been differentiated into children & newborn and adults. In 2020, the parenteral nutrition market from the adults consumer segment held a sizable revenue of about USD 3,010 million and is estimated to grow at a steady pace through 2027 driven by rising incidences of chronic diseases in adults and expanding geriatric population.

With respect to end-use, the market has been bifurcated into homecare, hospitals, clinics, and others. The homecare end-use segment is anticipated to exceed a valuation of USD 1,148 million by 2027, progressing at a notable CAGR over the forecast period. Surging prevalence of chronic conditions requiring long-term care, as along with cost-effectiveness and high patient convenience associated with homecare, is likely to bolster segmental adoption through the following years.

From the regional point of view, the Middle East & Africa parenteral nutrition market attained a considerable market share in 2020 and is slated to surpass a valuation of USD 468 million by the end of 2027. Increased occurrences of malnutrition and soaring number of preterm births across various countries in MEA are speculated to foster regional market outlook in the future.